Antibiotice Ia (ATB) — Net Asset Momentum
Antibiotice Ia (ATB) recorded a net asset momentum of 4.2% as of September 2025, with net assets of RON932.07 Million RON. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check ATB intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
Antibiotice Ia Net Asset Momentum (2020–2025)
This chart tracks Antibiotice Ia's year-over-year net asset growth across 6 annual reporting periods from 2020 to 2025. The most recent momentum reading is +4.2%, with net assets of RON932.07 Million RON as of September 2025. Read debt load of Antibiotice Ia for a breakdown of total debt and financial obligations.
Annual Net Asset History for Antibiotice Ia (2020–2025)
The table below shows the complete annual net asset history for Antibiotice Ia from 2020 to 2025, covering 6 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see ATB stock market capitalisation.
| Year | Net Assets (RON) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | RON932.07 Million | RON1.39 Billion | RON460.49 Million | ▲ +4.2% |
| 2024 | RON894.31 Million | RON1.28 Billion | RON384.95 Million | ▲ +5.6% |
| 2023 | RON846.96 Million | RON1.14 Billion | RON292.21 Million | ▲ +32.0% |
| 2022 | RON641.43 Million | RON856.47 Million | RON215.04 Million | ▲ +6.0% |
| 2021 | RON604.99 Million | RON895.39 Million | RON290.40 Million | ▲ +4.8% |
| 2020 | RON577.27 Million | RON863.00 Million | RON285.73 Million | — |